Quality Risks Seen from the Factory Floor
A real world view on pharmaceutical quality, sharing how early compromises, documentation gaps, vendor risks, and human behavior quietly evolve into recurring compliance and patient safety issues.
Q1. To begin, could you briefly describe your career history and how your work across quality control, quality assurance, and corporate QA roles has evolved over time?
From my experience, my career has developed step by step across Quality Control, Quality Assurance, and Corporate QA, mainly within pharmaceutical and regulated environments.
In QC, my focus was very much on working in line with pharma guidelines and regulated markets, ensuring day to day testing, compliance, and data correctness. This is where I acquired a deep understanding in understanding how laboratory results directly impact product release and patient safety.
When I moved into QA, the scope widened significantly. I became responsible for control over all factory processes, making sure there was documented evidence for every activity, fully aligned with GMP guidelines, ICH, USFDA, EU, and other global regulatory expectations. This included reviewing batch records, managing deviations, handling change control, and making sure that systems were not merely compliant on paper but defensible during inspections.
In my Corporate QA role, my responsibility became more oversight driven and risk focused. I was expected to keep a close eye on in process metrics throughout production, QC, QA, PPIC, stores, and warehouse areas. From my experience, …
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!